Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer.
Robertson MJ, Mier JW, Logan T, Atkins M, Koon H, Koch KM, Kathman S, Pandite LN, Oei C, Kirby LC, Jewell RC, Bell WN, Thurmond LM, Weisenbach J, Roberts S, Dar MM.
Robertson MJ, et al.
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4265-73. doi: 10.1158/1078-0432.CCR-06-0121.
Clin Cancer Res. 2006.
PMID: 16857801
Clinical Trial.